Flen Health believes biotech innovations can help to build a more secure life for all of us. Patients suffering from skin & wound disorders often have to, or will have to give up on activities they enjoy the most. Flen Health want to provide innovation that allows these patients to live the life they love. This is the original, present & future mission

Flen Health was established in 2000, building on the results of wound-treatment research performed by it’s MD, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health develops and commercialises innovative skin and wound healing solutions.

We hold an ISO 13485 certificate that covers all our operations. Thanks to the success on the Belgian market, we initiated international expansion into further affiliates in Luxembourg, the Netherlands, Germany, UK, Ireland, USA and UAE, managed by 100+ motivated employees. Flen Health products are distributed in 30+ countries across the globe.

UK product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel® RT.